🟢 Neuronetics is trading 15.24% up today after Q3 revenue growth and margin expansion

Neuronetics is trading 15.24% up at $2.65 after reporting third-quarter 2026 results before the market opened November 4.

• Revenue rose 12.5% to $42.0 million; gross margin increased to 52.2% from 45.9%.
• Adjusted EBITDA turned positive at $1.9 million. 2026 revenue guidance remains $160 million–$164 million; gross-margin guidance rose to 49%–50% from 48%–50%.
• Shares rose 9.71% on November 3; current trading volume was not provided.